Rayonier Advanced Materials director Scott M. Sutton resigns from board By Investing.com

The board resignation is less important for its standalone governance signal than for what it implies about deal-process dynamics. When a director steps away right after a strategic review and a rejected private-equity indication, it often reflects either disagreement over transaction path or an effort to clean up the governance posture ahead of renewed bidder outreach. That usually helps compress the “why now?” discount, but it also increases the odds of a faster, more binary catalyst window over the next 1-3 months rather than a slow fundamental rerating.

The real second-order effect is that RYAM is becoming a quasi-event-driven equity rather than a pure operating story. If the review is credible, the market should stop valuing it on mid-cycle pulp earnings and start anchoring to takeout/asset-sale optionality; that tends to lift downside support while capping upside until terms emerge. The flip side is that any delay, especially if management uses the review to justify more restructuring without a transaction path, can quickly unwind that optionality premium because the business still has weak earnings quality and limited tolerance for execution missteps.

Consensus likely underestimates how much the bar for a deal has shifted upward after the rejected prior approach. A buyer will likely need either a cleaner asset package, better financing conditions, or evidence that operating improvements are real enough to defend a higher multiple. That creates a narrow window where stock price can overshoot on rumor flow, but the more durable move requires a concrete process milestone, not just governance churn. In our view, the market is pricing the possibility of value realization but not enough of the time risk or the chance that the process ends in asset sales rather than a premium equity takeout.